Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $511.37 -0.91%
EPS Growth %: +22.2%
Financial Fact:
Selling, general and administrative expenses: 59.37M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +22.2%
Financial Fact:
Selling, general and administrative expenses: 59.37M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.
Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.
For earnings history and earnings-related data on Chemed (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Kaiser Aluminum (KALU) Misses Q3 EPS by 48c
- Oak Valley Bancorp (OVLY) Tops Q3 EPS by 77c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
